Inventor · disambiguated record
Marc A. Labroli
Also filed as: LABROLI MARC · LABROLI MARC A
17 granted patents·10 pending applications·263 citations·filing 2000–2023
93Inventor score
Files withSCHERING CORP6MERCK SHARP & DOHME5MERCK SHARP & DOHME LLC5GUZI TIMOTHY J3ALVAREZ CARMEN S1
Top patents by PatentIndex Score
27 records- 0197US6689765B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2002·Granted Feb 10, 2004·71 cites·12 claims
- 0297US6391865B1Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2000·Granted May 21, 2002·94 cites·19 claims
- 0392US7605155B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Oct 20, 2009·28 cites·14 claims
- 0490US8586576B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Nov 19, 2013·15 cites·15 claims
- 0590US7196078B2Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORPOARTION·Filed 2005·Granted Mar 27, 2007·26 cites·29 claims
- 0688US8580782B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Nov 12, 2013·14 cites·20 claims
- 0780US8603998B2Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitorsGUZI TIMOTHY J·Filed 2008·Granted Dec 10, 2013·5 cites·7 claims
- 0878US7384944B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2003·Granted Jun 10, 2008·6 cites·18 claims
- 0977US9206142B2Anilinopiperazine derivatives and methods of use thereofSHIPPS JR GERALD W·Filed 2007·Granted Dec 8, 2015·4 cites·21 claims
- 1066US11752128B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Sep 12, 2023·0 cites·3 claims
- 1165US8114879B2Piperazine derivatives useful as CCR5 antagonistsBAROUDY BAHIGE M·Filed 2008·Granted Feb 14, 2012·0 cites·14 claims
- 1265US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1363US11738010B2Oxazolidinones as TarO inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Aug 29, 2023·0 cites·14 claims
- 1461US2025326713A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1559US11141410B2Oxazolidinones as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·14 claims
- 1659US2025051341A1Pyrazolopyrimidine derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1757US11141403B2Benzimidazoles and indoles as taro inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 12, 2021·0 cites·1 claims
- 1856US8476278B2Thiazole Derivatives as protein kinase inhibitorsREDDY PANDURANGA ADULLA P·Filed 2008·Granted Jul 2, 2013·0 cites·2 claims
- 1956US2024083910A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesBERGER RICHARD·Filed 2021·Application pending·0 cites
- 2056US2024059693A1Fused bicyclic pyrazole derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2154US11413292B2Tricyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Aug 16, 2022·0 cites·18 claims
- 2254US2024067657A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 2352US12497405B2Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes virusesMERCK SHARP & DOHME LLC·Filed 2020·Granted Dec 16, 2025·0 cites·18 claims
- 2449US2012029204A1Synthesis of substituted-3-aminopyrazolesALVAREZ CARMEN S·Filed 2008·Application pending·0 cites
- 2541US2006247320A1Compounds for inhibiting KSP kinesin activitySCHERING CORP·Filed 2006·Application pending·0 cites
- 2640US2006281778A1Compounds for inhibiting KSP Kinesin activitySCHERING CORP·Filed 2006·Application pending·0 cites
- 2738US2013196986A1Triazolopyrazinones as p2x7 receptor antagonistsLABROLI MARC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc A. Labroli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →